MODERN METHODS OF DIAGNOSING HEPATITIS A

Authors

  • Munavvar Faxriddin qizi Kuchkorova Andijan State Medical Institute, Faculty of Postgraduate Medical Education and Retraining; Department of Pediatric Endocrinology, Phthisiology, Infectious Diseases, and Epidemiology Author

Keywords:

hepatitis A, HAV, viral hepatitis, anti-HAV IgM, anti-HAV IgG, HAV-RNA, PCR, ELISA, ALT, bilirubin, serological diagnosis, differential diagnosis, laboratory diagnostics.

Abstract

Hepatitis A is an acute viral infection caused by the hepatitis A virus (HAV), primarily transmitted via the fecal-oral route, and characterized by liver damage. Since the clinical symptoms of the disease resemble those of other acute viral hepatitises, an etiological diagnosis based solely on medical history and clinical examination is insufficient. This article analyzes modern principles for diagnosing hepatitis A, the diagnostic significance of clinical-biochemical markers, the detection of anti-HAV IgM and IgG antibodies, and the capabilities of detecting HAV-RNA using the polymerase chain reaction (PCR) method. Particular emphasis is placed on the role of anti-HAV IgM in confirming acute infection, the indication of immunity from past infection or vaccination by anti-HAV IgG, and the diagnostic value of PCR during the early stages of infection. In modern practice, the comprehensive evaluation of laboratory tests alongside clinical and epidemiological data is considered essential for enhancing diagnostic accuracy.

References

1.World Health Organization (WHO). Hepatitis A. Fact sheet. WHO, 2026. Centers for Disease Control and Prevention (CDC). Clinical Screening and Diagnosis for Hepatitis A. Updated January 11, 2024.

2.Centers for Disease Control and Prevention (CDC). Hepatitis A: Manual for the Surveillance of Vaccine-Preventable Diseases.

3.Centers for Disease Control and Prevention (CDC). Hepatitis A Surveillance Guidance: Interpretation of Laboratory Test Results.

4.Centers for Disease Control and Prevention (CDC). Pink Book: Chapter 9 — Hepatitis A.

5.World Health Organization. WHO Vaccine-Preventable Diseases Surveillance Standards: Hepatitis A. WHO.

6.World Health Organization. Immunological Basis for Immunization Series: Module 18 — Hepatitis A. WHO.

7.Centers for Disease Control and Prevention. Viral Hepatitis — STI Treatment Guidelines: Hepatitis A.

8.Centers for Disease Control and Prevention. Clinical Overview of Viral Hepatitis.

9.World Health Organization. WHO Technical Considerations: Viral Hepatitis Surveillance and Case Definitions. WHO.

Downloads

Published

2026-09-23